APA

Janikova A., Bortlicek Z., Campr V., Kopalova N., Benesova K., Belada D., Prochazka V., Pytlik R., Vokurka S., Pirnos J., Duras J., Mocikova H., Mayer J. & Trneny M. (20160406). Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?. : Leukemia & lymphoma.

Chicago

Janikova Andrea, Bortlicek Zbynek, Campr Vit, Kopalova Natasa, Benesova Katerina, Belada David, Prochazka Vit, Pytlik Robert, Vokurka Samuel, Pirnos Jan, Duras Juraj, Mocikova Heidi, Mayer Jiri and Trneny Marek. 20160406. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?. : Leukemia & lymphoma.

Harvard

Janikova A., Bortlicek Z., Campr V., Kopalova N., Benesova K., Belada D., Prochazka V., Pytlik R., Vokurka S., Pirnos J., Duras J., Mocikova H., Mayer J. and Trneny M. (20160406). Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?. : Leukemia & lymphoma.

MLA

Janikova Andrea, Bortlicek Zbynek, Campr Vit, Kopalova Natasa, Benesova Katerina, Belada David, Prochazka Vit, Pytlik Robert, Vokurka Samuel, Pirnos Jan, Duras Juraj, Mocikova Heidi, Mayer Jiri and Trneny Marek. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?. : Leukemia & lymphoma. 20160406.